Title : Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period - Kadowaki_2017_Expert.Opin.Pharmacother_18_1291